Cosmo Technologies Ltd

General

Total Cases36

Active Cases2

Patents51

CourtsD. Delaware D. New Jersey D. Maryland

TypeOperating Company

Elite Ratings

--

cosmopharma.com

cosmo-pharmaceuticals

cosmo-technologies

Ratings

Experience

Grade

Trend

DCT

L3

E

PTAB

L3

B

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
11/26/24	Cassiopea Spa v. Aurobindo Pharma Ltd 2:24-CV-10734 ( D. NJ )	AO120 Patent Form filed. (Attachments: # [1] Complaint, # [2] Exhibit 1, # [3] Exhibit 2, # [4] Exhibit 3, # [5] Exhibit 4, # [6] Exhibit 5, # [7] Exhibit 6, # [8] Exhibit 7, # [9] Exhibit 8, # [10] Exhibit 9, # [11] Exhibit 10, # [12] Exhibit 11, # [13] Exhibit 12, # [14] Exhibit 13, # [15] Exhibit 14, # [16] Exhibit 15) (dam) (Entered: 11/26/2024)
11/26/24	Cassiopea Spa v. Aurobindo Pharma Ltd 2:24-CV-10734 ( D. NJ )	SUMMONS ISSUED as to AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dam) (Entered: 11/26/2024)
11/26/24	Cassiopea Spa v. Aurobindo Pharma Ltd 2:24-CV-10734 ( D. NJ )	Magistrate Judge James B. Clark added. (jr) (Entered: 11/26/2024)
11/25/24	Cassiopea Spa v. Aurobindo Pharma Ltd 2:24-CV-10734 ( D. NJ )	Corporate Disclosure Statement by SUN PHARMACEUTICAL INDUSTRIES, INC., CASSIOPEA S.P.A., COSMO PHARMACEUTICALS N.V., SUN PHARMACEUTICAL INDUSTRIES, LTD.. (MILLER, GREGORY) (Entered: 11/25/2024)
11/25/24	Cassiopea Spa v. Aurobindo Pharma Ltd 3:24-CV-10734 ( D. NJ )	Corporate Disclosure Statement by SUN PHARMACEUTICAL INDUSTRIES, INC., CASSIOPEA S.P.A., COSMO PHARMACEUTICALS N.V., SUN PHARMACEUTICAL INDUSTRIES, LTD.. (MILLER, GREGORY) (Entered: 11/25/2024)
11/25/24	Cassiopea Spa v. Aurobindo Pharma Ltd 2:24-CV-10734 ( D. NJ )	COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15832640), filed by COSMO PHARMACEUTICALS N.V., CASSIOPEA S.P.A., SUN PHARMACEUTICAL INDUSTRIES, LTD., SUN PHARMACEUTICAL INDUSTRIES, INC.. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 7, # [8] Exhibit 8, # [9] Exhibit 9, # [10] Exhibit 10, # [11] Exhibit 11, # [12] Exhibit 12, # [13] Exhibit 13, # [14] Exhibit 14, # [15] Exhibit 15, # [16] Civil Cover Sheet)(MILLER, GREGORY) (Entered: 11/25/2024) COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15832640), filed by COSMO PHARMACEUTICALS N.V., CASSIOPEA S.P.A., SUN PHARMACEUTICAL INDUSTRIES, LTD., SUN PHARMACEUTICAL INDUSTRIES, INC.. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 7, # [8] Exhibit 8, # [9] Exhibit 9, # [10] Exhibit 10, # [11] Exhibit 11, # [12] Exhibit 12, # [13] Exhibit 13, # [14] Exhibit 14, # [15] Exhibit 15, # [16] Civil Cover Sheet)(MILLER, GREGORY) (Entered: 11/25/2024)
11/25/24	Cassiopea Spa v. Aurobindo Pharma Ltd 3:24-CV-10734 ( D. NJ )	COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15832640), filed by COSMO PHARMACEUTICALS N.V., CASSIOPEA S.P.A., SUN PHARMACEUTICAL INDUSTRIES, LTD., SUN PHARMACEUTICAL INDUSTRIES, INC.. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 7, # [8] Exhibit 8, # [9] Exhibit 9, # [10] Exhibit 10, # [11] Exhibit 11, # [12] Exhibit 12, # [13] Exhibit 13, # [14] Exhibit 14, # [15] Exhibit 15, # [16] Civil Cover Sheet)(MILLER, GREGORY) (Entered: 11/25/2024) COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15832640), filed by COSMO PHARMACEUTICALS N.V., CASSIOPEA S.P.A., SUN PHARMACEUTICAL INDUSTRIES, LTD., SUN PHARMACEUTICAL INDUSTRIES, INC.. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 7, # [8] Exhibit 8, # [9] Exhibit 9, # [10] Exhibit 10, # [11] Exhibit 11, # [12] Exhibit 12, # [13] Exhibit 13, # [14] Exhibit 14, # [15] Exhibit 15, # [16] Civil Cover Sheet)(MILLER, GREGORY) (Entered: 11/25/2024)
12/16/21	Valeant Pharma Intl v. Actavis Laboratories FL Inc 1:18-CV-01288 ( D. DE )	ORAL ORDER: IT IS HEREBY ORDERED that the Court will hear oral argument on the pending motion on January 18, 2022 beginning at 2:00 p.m. in Courtroom 6B. Each side will be allocated up to twenty (20) minutes to present its argument. ORDERED by Judge Leonard P. Stark on 12/16/21. (ntl)
05/10/21	Valeant Pharma Intl v. Actavis Laboratories FL Inc 1:18-CV-01288 ( D. DE )	DECLARATION re [183] Reply Brief in Support of Defendants' Motion for Attorneys' Fees by Actavis Laboratories FL Inc. , Actavis Pharma Inc. , Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. . (Attachments: # [1] Exhibit 1)(Phillips, John)
05/10/21	Valeant Pharma Intl v. Actavis Laboratories FL Inc 1:18-CV-01288 ( D. DE )	REPLY BRIEF re [171] MOTION for Attorney Fees filed by Actavis Laboratories FL Inc. , Actavis Pharma Inc. , Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. . (Phillips, John)